Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-102,094
Closed -$679K 4669
2025
Q4
$679K Buy
102,094
+82,325
+416% +$558K ﹤0.01% 3154
2025
Q3
$121K Sell
19,769
-104,091
-84% -$812K ﹤0.01% 3440
2025
Q2
$1.14M Sell
123,860
-67,998
-35% -$696K ﹤0.01% 2166
2025
Q1
$2.31M Buy
191,858
+157,914
+465% +$2.07M ﹤0.01% 1646
2024
Q4
$375K Sell
33,944
-18,055
-35% -$254K ﹤0.01% 2662
2024
Q3
$842K Buy
51,999
+11,299
+28% +$158K ﹤0.01% 2220
2024
Q2
$442K Sell
40,700
-92,051
-69% -$1.13M ﹤0.01% 2423
2024
Q1
$1.86M Buy
132,751
+6,297
+5% +$81.8K ﹤0.01% 1538
2023
Q4
$1.33M Buy
126,454
+51,882
+70% +$464K ﹤0.01% 1900
2023
Q3
$682K Buy
74,572
+40,572
+119% +$364K ﹤0.01% 2139
2023
Q2
$247K Buy
34,000
+1,500
+5% +$12.9K ﹤0.01% 2577
2023
Q1
$275K Buy
32,500
+13,844
+74% +$125K ﹤0.01% 2458
2022
Q4
$140K Buy
+18,656
New +$144K ﹤0.01% 2456
2022
Q3
Sell
-31,621
Closed -$367K 2560
2022
Q2
$367K Buy
31,621
+18,749
+146% +$221K ﹤0.01% 1944
2022
Q1
$144K Buy
+12,872
New +$110K ﹤0.01% 2386
2021
Q4
Sell
-94,520
Closed -$720K 4425
2021
Q3
$720K Sell
94,520
-120,120
-56% -$1.24M ﹤0.01% 2928
2021
Q2
$2.71M Buy
+214,640
New +$2.36M 0.01% 1625
2019
Q1
Sell
-44,577
Closed -$530K 3137
2018
Q4
$530K Buy
+44,577
New +$636K ﹤0.01% 2064

Other funds holding EOLS

John Overdeck's EOLS Position: Q1 2026 in Review

John Overdeck sold out of Evolus (EOLS) in Q1 2026, closing a stake of 102,094 shares — an estimated $679K sold.

John Overdeck first reported a position in EOLS in Q4 2018 and held it in 18 quarters. The position peaked at $2.71M in Q2 2021. 147 funds tracked by Wall St. Rank hold EOLS as of Q1 2026.

  • John Overdeck reported no remaining Evolus position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 102,094 Evolus shares in Q1 2026, an estimated $679K.
  • John Overdeck first reported a position in Evolus in Q4 2018 and held it in 18 quarters.
  • John Overdeck's Evolus position peaked at $2.71M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held Evolus as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.